CompletedPhase 4

Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing

12 participantsStarted 2015-02

Plain-language summary

This is a single-centre, open label study, aiming to evaluate the efficacy of beclomethasone dipropionate applied for 12 weeks with a dose of 400 µg twice a day (total dose 800 µg nebulized), on airway resistance and reactances (measured with Rint and FOT techniques) in children with recurrent wheezing, aged 2-5 years. In addition, clinic score as frequency of symptoms and exacerbations, will be assessed.

Who can participate

Age range2 Years – 5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. one parent with asthma
✓. Atopic Dermatitis
✓. sensibilisation to air allergen
✓. Food sensibilization
✓. wheezing also not during the infective episodes
✓. eosinophilia (\>4%)

What they're measuring

Lung fuction with Rint and FOT

Timeframe: 12 Weeks

Trial details

NCT IDNCT02381158

SponsorIstituto per la Ricerca e l'Innovazione Biomedica

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Wheezing trials